Impairment of the ubiquitin‐proteasome system in desminopathy mouse hearts
暂无分享,去创建一个
Jinbao Liu | Wei Huang | R. Mestril | Xuejun Wang | Hanqiao Zheng | Kathleen M. Horak | Quanhai Chen
[1] P. Ping,et al. The Murine Cardiac 26S Proteasome: An Organelle Awaiting Exploration , 2005, Annals of the New York Academy of Sciences.
[2] K. Lindenberg,et al. Impairment of the ubiquitin-proteasome system by truncated cardiac myosin binding protein C mutants. , 2005, Cardiovascular research.
[3] Cam Patterson,et al. Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[4] E. Hol,et al. Protein quality control in Alzheimer's disease by the ubiquitin proteasome system , 2004, Progress in Neurobiology.
[5] Xuejun Wang,et al. Genetic modification of the heart: chaperones and the cytoskeleton. , 2004, Journal of molecular and cellular cardiology.
[6] Da-Zhi Wang,et al. Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex. , 2004, The Journal of clinical investigation.
[7] John Q Trojanowski,et al. Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs , 2004, Nature Medicine.
[8] Jinbao Liu,et al. In situ dynamically monitoring the proteolytic function of the ubiquitin-proteasome system in cultured cardiac myocytes. , 2004, American journal of physiology. Heart and circulatory physiology.
[9] J. Saffitz,et al. Desmin-related cardiomyopathy in transgenic mice: a cardiac amyloidosis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[10] S. Lipton,et al. Molecular pathways to neurodegeneration , 2004, Nature Medicine.
[11] C. Ross,et al. Protein aggregation and neurodegenerative disease , 2004, Nature Medicine.
[12] Hui-Chen Hsu,et al. Regulation of apoptosis proteins in cancer cells by ubiquitin , 2004, Oncogene.
[13] N. Nukina,et al. Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease , 2004, Nature Medicine.
[14] Wei Huang,et al. &agr;B-Crystallin Modulates Protein Aggregation of Abnormal Desmin , 2003, Circulation research.
[15] T. Dawson,et al. Molecular Pathways of Neurodegeneration in Parkinson's Disease , 2003, Science.
[16] K. Lindsten,et al. A transgenic mouse model of the ubiquitin/proteasome system , 2003, Nature Biotechnology.
[17] Jiling Song,et al. Imaging 26S proteasome activity and inhibition in living mice , 2003, Nature Medicine.
[18] P. Kloetzel,et al. Inhibition of Proteasome Activity Induces Concerted Expression of Proteasome Genes and de Novo Formation of Mammalian Proteasomes* , 2003, Journal of Biological Chemistry.
[19] H. Goebel. Congenital myopathies at their molecular dawning , 2003, Muscle & nerve.
[20] J. Woodgett,et al. Stabilization of β-catenin by a Wnt-independent mechanism regulates cardiomyocyte growth , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[21] J. Schaper,et al. Progression From Compensated Hypertrophy to Failure in the Pressure-Overloaded Human Heart: Structural Deterioration and Compensatory Mechanisms , 2003, Circulation.
[22] Junying Yuan,et al. Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders , 2003, Nature.
[23] A. Ciechanover,et al. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. , 2002, Physiological reviews.
[24] T. Hewett,et al. Expression of R120G–αB-Crystallin Causes Aberrant Desmin and αB-Crystallin Aggregation and Cardiomyopathy in Mice , 2001 .
[25] G. Dorn,et al. Mouse Model of Desmin-Related Cardiomyopathy , 2001, Circulation.
[26] W. Schaper,et al. Increased expression of cytoskeletal, linkage, and extracellular proteins in failing human myocardium. , 2000, Circulation research.
[27] M. Dalakas,et al. Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene. , 2000, The New England journal of medicine.
[28] G. Taffet,et al. The absence of desmin leads to cardiomyocyte hypertrophy and cardiac dilation with compromised systolic function. , 1999, Journal of molecular and cellular cardiology.
[29] M. Prevost,et al. A missense mutation in the αB-crystallin chaperone gene causes a desmin-related myopathy , 1998, Nature Genetics.
[30] A. Friedl,et al. Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy. , 1991, Circulation.
[31] T. Hewett,et al. Expression of R120G-alphaB-crystallin causes aberrant desmin and alphaB-crystallin aggregation and cardiomyopathy in mice. , 2001, Circulation research.
[32] R. Kopito,et al. Impairment of the ubiquitin-proteasome system by protein aggregation. , 2001, Science.
[33] H. Lehrach,et al. Membrane filter assay for detection of amyloid-like polyglutamine-containing protein aggregates. , 1999, Methods in enzymology.
[34] J. Li,et al. The FASEB Journal express article 10.1096/fj.05-3973fje. Published online September 27, 2005. , 2022 .